Top

WHO gives Green Signal to Corona Vaccine of Serum Institute for Emergency Use

Pune-based Serum Institute of India has developed this vaccine under the name of covishield. With this approval, millions of doses of vaccine will reach countries around the world with the help of the United Nations to deal with the pandemic.

Yogita S.

Yogita S.By Yogita S.

Published on 16 Feb 2021 5:40 AM GMT

WHO gives Green Signal to Corona Vaccine of Serum Institute for Emergency Use
X
Chinese COVID-19 vaccine candidate produces immune response in animals: Study
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print

New Delhi: The World Health Organization (WHO) has granted emergency use approval to AstraZeneca and the University of Oxford's Corona vaccine. Pune-based Serum Institute of India has developed this vaccine under the name of covishield. With this approval, millions of doses of vaccine will reach countries around the world with the help of the United Nations to deal with the pandemic.

Emergency approval to Serum Vaccine:

The United Nations health agency said in a statement on Monday that it had granted emergency approval to the Astrazeneca vaccine. That being made by the Serum Institute of India and South Korea's AstraZeneca-SKBio. With the approval of the Corona vaccine of AstraZeneca by the WHO. Its dose will be sure to reach in poor countries as well.

ALSO READ: India provides 2 Crore Corona vaccine doses to 20 Countries

Last week the WHO expert group recommended the use of the AstraZeneca vaccine for people over 18 years of age. Although the WHO does not approve or regulate the vaccine. It assesses the safety and effectiveness of the vaccine for developing countries in which the drug regulatory regime is not robust.

Astrazeneca and Oxford Vaccines:

So far 109 million people worldwide have been infected with Corona. At the same time, over 24 lakh people have died. Even after this, many countries of the world have not yet started vaccination programs. And even rich countries are facing shortage of vaccine supplements. The demand for the vaccine is so high that manufacturers are struggling to accelerate production.

AstraZeneca and Oxford vaccines have already been approved for emergency use in more than 50 countries, including the UK, India, Argentina and Mexico. This vaccine is quite cheap and it is also easy to keep.

Stay tuned with the newstrack to get fastest updates. Click @englishnewstrack to follow us on Facebook and @newstrackmedia to follow on Twitter.

Yogita S.

Yogita S.

Media Graduate, News Editor and PR Enthusiast.

Next Story